BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 29227538)

  • 41. Loss of metallothionein predisposes mice to diethylnitrosamine-induced hepatocarcinogenesis by activating NF-kappaB target genes.
    Majumder S; Roy S; Kaffenberger T; Wang B; Costinean S; Frankel W; Bratasz A; Kuppusamy P; Hai T; Ghoshal K; Jacob ST
    Cancer Res; 2010 Dec; 70(24):10265-76. PubMed ID: 21159647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inactivation of p27kip1 promotes chemical hepatocarcinogenesis through enhancing inflammatory cytokine secretion and STAT3 signaling activation.
    Guo J; Ma Q; Zhou X; Fan P; Shan T; Miao D
    J Cell Physiol; 2013 Oct; 228(10):1967-76. PubMed ID: 23460367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic deletion of AEG-1 prevents hepatocarcinogenesis.
    Robertson CL; Srivastava J; Siddiq A; Gredler R; Emdad L; Rajasekaran D; Akiel M; Shen XN; Guo C; Giashuddin S; Wang XY; Ghosh S; Subler MA; Windle JJ; Fisher PB; Sarkar D
    Cancer Res; 2014 Nov; 74(21):6184-93. PubMed ID: 25193383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SJSZ glycoprotein (38 kDa) modulates macrophage type 1/2-related factors at hepatocarcinogenic stage in N-nitrosodiethylamine-treated Balb/c.
    Lee J; Lim KT
    Mol Cell Biochem; 2013 Jan; 372(1-2):17-26. PubMed ID: 22956448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
    Pittala S; Krelin Y; Shoshan-Barmatz V
    Neoplasia; 2018 Jun; 20(6):594-609. PubMed ID: 29747160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
    Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
    Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autophagy-induced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin.
    Tan HY; Wang N; Man K; Tsao SW; Che CM; Feng Y
    Cell Death Dis; 2015 Oct; 6(10):e1942. PubMed ID: 26492375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
    Wen LZ; Ding K; Wang ZR; Ding CH; Lei SJ; Liu JP; Yin C; Hu PF; Ding J; Chen WS; Zhang X; Xie WF
    Cancer Res; 2018 Aug; 78(16):4680-4691. PubMed ID: 29776962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Superoxide deficiency attenuates promotion of hepatocarcinogenesis by cytotoxicity in NADPH oxidase knockout mice.
    Parzefall W; Freiler C; Lorenz O; Koudelka H; Riegler T; Nejabat M; Kainzbauer E; Grasl-Kraupp B; Schulte-Hermann R
    Arch Toxicol; 2015 Aug; 89(8):1383-93. PubMed ID: 25182417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AIM2 deficiency reduces the development of hepatocellular carcinoma in mice.
    Martínez-Cardona C; Lozano-Ruiz B; Bachiller V; Peiró G; Algaba-Chueca F; Gómez-Hurtado I; Such J; Zapater P; Francés R; González-Navajas JM
    Int J Cancer; 2018 Dec; 143(11):2997-3007. PubMed ID: 30133699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway.
    Verma A; Singh D; Anwar F; Bhatt PC; Al-Abbasi F; Kumar V
    Inflammopharmacology; 2018 Feb; 26(1):133-146. PubMed ID: 28608141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between liver X receptor-α and neuron-derived orphan nuclear receptor-1 in Kupffer cells of C57BL/6 mice during inflammation.
    He K; Dai ZY; Li PZ; Zhu XW; Gong JP
    Mol Med Rep; 2015 Oct; 12(4):6098-104. PubMed ID: 26239564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma.
    Li W; Xiao J; Zhou X; Xu M; Hu C; Xu X; Lu Y; Liu C; Xue S; Nie L; Zhang H; Li Z; Zhang Y; Ji F; Hui L; Tao W; Wei B; Wang H
    J Clin Invest; 2015 Nov; 125(11):4239-54. PubMed ID: 26457732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling.
    Yang Y; Guo Y; Tan S; Ke B; Tao J; Liu H; Jiang J; Chen J; Chen G; Wu B
    Nat Commun; 2015 Jun; 6():7369. PubMed ID: 26077142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
    Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
    BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis.
    Waidmann O; Pleli T; Weigert A; Imelmann E; Kakoschky B; Schmithals C; Döring C; Frank M; Longerich T; Köberle V; Hansmann ML; Brüne B; Zeuzem S; Piiper A; Dikic I
    Sci Rep; 2020 Oct; 10(1):16264. PubMed ID: 33004985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.
    Meng Z; Wang X; Gan Y; Zhang Y; Zhou H; Ness CV; Wu J; Lou G; Yu H; He C; Xu R; Huang W
    J Hepatol; 2012 Nov; 57(5):1004-12. PubMed ID: 22728874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
    Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
    Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.